KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Goodwill (2016 - 2025)

Jazz Pharmaceuticals has reported Goodwill over the past 16 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly Goodwill rose 6.58% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 6.58% year-over-year, with the annual reading at $1.8 billion for FY2025, 6.58% up from the prior year.
  • Goodwill was $1.8 billion for Q4 2025 at Jazz Pharmaceuticals, roughly flat from $1.8 billion in the prior quarter.
  • Over five years, Goodwill peaked at $1.9 billion in Q2 2021 and troughed at $938.4 million in Q1 2021.
  • The 5-year median for Goodwill is $1.7 billion (2023), against an average of $1.7 billion.
  • Biggest five-year swings in Goodwill: surged 105.63% in 2021 and later decreased 13.89% in 2022.
  • Tracing JAZZ's Goodwill over 5 years: stood at $1.8 billion in 2021, then fell by 7.38% to $1.7 billion in 2022, then grew by 3.57% to $1.8 billion in 2023, then dropped by 2.1% to $1.7 billion in 2024, then rose by 6.58% to $1.8 billion in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $1.8 billion, $1.8 billion, and $1.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.